Vitreous Pathology

  • Peter Bracha
  • Gian Paolo Giuliari
  • Thomas A. Ciulla
Part of the Modeling and Simulation in Science, Engineering and Technology book series (MSSET)


The vitreous is involved in a wide variety of pathologies. The vitreoretinal interface is the site of adhesion between the posterior vitreous cortex and the retina’s internal limiting membrane, and a pathological interaction between these two surfaces accounts for pathologies including vitreomacular traction, macular holes, epiretinal membranes, retinal tears and detachments, and macular edema. The vitreous has a structural role in retinal neovascularization, in particular proliferative diabetic retinopathy, retinopathy of prematurity, and familial exudative vitreoretinopathy. Metabolic disorders of the vitreous include amyloidosis and asteroid hyalosis. These diseases of the vitreous and vitreoretinal interface will be discussed in this chapter.


  1. 1.
    Schneider, E.W. and M.W. Johnson, Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review. Clin Ophthalmol, 2011. 5: p. 1151-65.Google Scholar
  2. 2.
    Snead, M.P., et al., Stickler syndrome, ocular-only variants and a key diagnostic role for the ophthalmologist. Eye (Lond), 2011. 25(11): p. 1389-400.Google Scholar
  3. 3.
    Robin, N.H., R.T. Moran, and L. Ala-Kokko, Stickler Syndrome, in GeneReviews(R), M.P. Adam, et al., Editors. 1993, University of Washington, SeattleGoogle Scholar
  4. 4.
    Meredith, S.P., et al., Clinical characterisation and molecular analysis of Wagner syndrome. Br J Ophthalmol, 2007. 91(5): p. 655-9.Google Scholar
  5. 5.
    Shastry, B.S., Persistent hyperplastic primary vitreous: congenital malformation of the eye. Clin Exp Ophthalmol, 2009. 37(9): p. 884-90.Google Scholar
  6. 6.
    Milston, R., M.C. Madigan, and J. Sebag, Vitreous floaters: Etiology, diagnostics, and management. Surv Ophthalmol, 2016. 61(2): p. 211-27.CrossRefGoogle Scholar
  7. 7.
    Sebag, J., Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol, 1987. 225(2): p. 89-93.CrossRefGoogle Scholar
  8. 8.
    Le Goff, M.M. and P.N. Bishop, Adult vitreous structure and postnatal changes. Eye (Lond), 2008. 22(10): p. 1214-22.CrossRefGoogle Scholar
  9. 9.
    Johnson, M.W., Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol, 2010. 149(3): p. 371-82.e1.Google Scholar
  10. 10.
    Schwab, C., et al., Prevalence of early and late stages of physiologic PVD in emmetropic elderly population. Acta Ophthalmol, 2012. 90(3): p. e179-84.Google Scholar
  11. 11.
    Neffendorf, J.E., et al., Ocriplasmin for symptomatic vitreomacular adhesion. Cochrane Database Syst Rev, 2017. 10: p. Cd011874.Google Scholar
  12. 12.
    Gass, J.D., Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol, 1988. 106(5): p. 629-39.CrossRefGoogle Scholar
  13. 13.
    Krzystolik, M.G., T.A. Ciulla, and A.R. Frederick, Jr., Evolution of a full-thickness macular hole. Am J Ophthalmol, 1998. 125(2): p. 245-7.CrossRefGoogle Scholar
  14. 14.
    Bainbridge, J., E. Herbert, and Z. Gregor, Macular holes: vitreoretinal relationships and surgical approaches. Eye (Lond), 2008. 22(10): p. 1301-9.CrossRefGoogle Scholar
  15. 15.
    Ciulla, T.A. and R.D. Pesavento, Epiretinal fibrosis. Ophthalmic Surg Lasers, 1997. 28(8): p. 670-9.Google Scholar
  16. 16.
    Shu, D.Y. and F.J. Lovicu, Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis. Prog Retin Eye Res, 2017.Google Scholar
  17. 17.
    Bu, S.C., et al., Idiopathic epiretinal membrane. Retina, 2014. 34(12): p. 2317-35.CrossRefGoogle Scholar
  18. 18.
    Wand, M., T.R. Smith, and D.G. Cogan, Cholesterosis bulbi: the ocular abnormality nown as synchysis scintillans. Am J Ophthalmol, 1975. 80(2): p. 177-83.CrossRefGoogle Scholar
  19. 19.
    Golan, S. and A. Loewenstein, Surgical treatment for macular edema. Semin Ophthalmol, 2014. 29(4): p. 242-56.CrossRefGoogle Scholar
  20. 20.
    Haller, J.A., et al., Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology, 2010. 117(6): p. 1087-1093.e3.Google Scholar
  21. 21.
    Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol, 2003. 121(12): p. 1684-94.Google Scholar
  22. 22.
    Mintz-Hittner, H.A., K.A. Kennedy, and A.Z. Chuang, Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med, 2011. 364(7): p. 603-15.CrossRefGoogle Scholar
  23. 23.
    Gilmour, D.F., Familial exudative vitreoretinopathy and related retinopathies. Eye (Lond), 2015. 29(1): p. 1-14.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Peter Bracha
    • 1
  • Gian Paolo Giuliari
    • 1
  • Thomas A. Ciulla
    • 1
    • 2
  1. 1.Department of OphthalmologyIndiana University School of MedicineIndianapolisUSA
  2. 2.Midwest Eye InstituteIndianapolisUSA

Personalised recommendations